An AMPK activator- 5-aminoimidazole-4-carboxamide riboside (AICAR)- is metabolized into 5-aminoimidazole-4-carboxamide ribotide (ZMP) [121], which elicits Nrf2 activation in HCC [122]. Here, NFE2L2 is linked to hepatocellular carcinoma.